Deskripsi produk
Indikasi
Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).
Mekanisme Kerja
IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]
Farmakologi
12.1 Mekanisme Kerja IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]
Dosis dan Penggunaan
2.1 3 PFIC BYLVAY 40 mcg/kg, , 1 3 , 40 mcg/kg , 120 mcg/kg, 6 mg BYLVAY 19.5 kg BYLVAY 19.5 kg
Peringatan
5.1 BYLVAY (DILI) PFIC ALGS , 6 DILI ,2 ALGS PFIC , 6 8 , , BYLVAY ,
Kontraindikasi
IBAT BYLVAY , [ Peringatan 5.1 ]
Interaksi Obat
7.1 , BYLVAY 4 4 [ Dosis dan Penggunaan (2.3)] , BYLVAY
Efek Samping
[ Peringatan(5.1)] [ Peringatan(5.2)] [ Peringatan(5.3)] 6.1 , , PFIC 1 24 , BYLVAY 40 mcg/kg 120 mcg/kg [ (14.1)]
